Labcorp Announces Enhanced Global Trial Connect Platform for Sponsors, Investigator Sites

07:53 AM EDT, 08/31/2026 (MT Newswires) -- Labcorp (LH) has launched an enhanced version of its Global Trial Connect clinical trial platform, adding digital tools for better study visibility and simplifying workflows, the company said Monday. The redesigned Labcorp Sponsor and Labcorp Investigator portals include integrated study oversight, reporting, and supply-tracking tools, along with a unified dashboard covering study, site, sample, and supply data, the company said. The platform also adds in-portal kit ordering and end-to-end sample tracking, Labcorp said.